mentioned alternative dosing approaches in this 2023 report, including the microdosing chart shown below, this was suggested only as a temporary solution during semaglutide shortages — not as a ...

The primary outcome was based on two lowest semaglutide dose sequences, i.e., 0.25 mg/week for weeks 1-4 and 0.5 mg/week for weeks 5-8. However, the week 9 dose was flexible and could be as high ...